Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant tuberculosis

Tuberculosis and Respiratory Diseases

Volumn 59, Issue 2, 2005, Pages 179-185

  Park, Seung Kyu ^a,b   Kim, Jin Hee ^a   Kim, Jun Ho ^a  

^a National Masan Hospital   (South Korea)

^b National Masan TB Hospital   (South Korea)

Author keywords

Lung surgery; MDR TB; Pulmonary tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; DISEASE ACTIVITY; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; LOBECTOMY; LUNG RESECTION; LUNG SURGERY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; REINFECTION; SEGMENTECTOMY; SPUTUM SMEAR; SURGICAL TECHNIQUE; TUBERCULOSIS;

EID: 27644489743     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2005.59.2.179     Document Type: Article

References (26)

1. Iseman MD. Treatment of multidrug resistant tuberculosis. N Engl J Med 1993;329:784-91.
2. Report on the 7th tuberculosis prevalence survey in Korea. Ministry of Health and Welfare, Korean National Tuberculosis Association; 1996. p.1-180.
3. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug resistant tuberculosis. J Infect Dis 2002;185:1197-202.
4. Park SK, Choi IH, Kim CM, Kim CT, Song SD. Clinical study of pulmonary tuberculosis for admitted patients at National Masan Tuberculosis Hospital Tuberc Respir Dis 1997;44:241-50.
5. Park SK, Lee IH, Kim BJ. Clinical observational study of pulmonary tuberculosis for admitted patients at a National Tuberculosis Hospital: comparison with the previous results in 1995. Tuberc Respir Dis 2005; 58:392-8.
6. Canetti G, Grosset J. Percentage of isoniazid-resistant and streptomycin-resistant variants in wild strains of Mycobacterium tuberculosis on Loewenstein-Jensen medium. Ann Inst Pasteur 1961;101:28-46.
7. Iseman MD, Madsen L, Goble M, Pomerantz M. Surgical intervention of pulmonary disease caused by drug resistant Mycobacterium tuberuclosis. Am Rev Respir Dis 1990;141:623-5.
8. van Leuven M, de Groot M, Shean KP, von Oppell UO, Willcox PA. Pulmonary resection as an adjunct in the treatment of multiple drug-resistant tuberculosis. Ann Thorac Surg 1997;63:1368-73.
9. Pomerantz M, Brown JM. Surgery in the treatment of multidrug resistant tuberculosis. Clin Chest Med 1997;18:123-30.
10. Sung SW, Kang CH, Kim YT, Kim JH. Surgical management of multidrug resistant pulmonary tuberculosis. Korean J Thorac Cardiovasc Surg 1999;32:287-93.
11. Kwon ES, Ha HC, Hwang SH, Lee HY, Park SK, Song SD. Pulmonary resection in the treatment of multidrug-resistant tuberculosis. Tuberc Respir Dis 1998; 45:1143-53.
12. Park SK, Lee CM, Heu JP, Song SD. A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug resistant tuberculosis. Int J Tuberc Lung Dis 2002;6:143-9.
13. Sim YS. Update in refractory pulmonary tuberculosis. J Korean Med Assoc 1998;39:1277-86.
14. Park SK, Choi IH, Song SD. Clinical course of cavitary lesions in pulmonary tuberculosis. Tuberc Respir Dis 1996;43:323-30.
15. Jun HJ, Hahn DK, Park SK, Song SD, Choi PC, Woo JS. Clinical evaluation of surgical resection of surgical resection on, pulmonary tuberculosis: multiple drug resistant tuberculosis. Korean J Thorac Cardiovasc Surg 1997;30:786-92.
16. Pomerantz M, Brown J. The surgical management of tuberculosis. Semin Thorac Cardiovasc Surg 1995;7:108-11.
17. Sim SB, Kim QJ, Kim BS, Jang DC. Clinical evaluation of posititve sputum AFB cases following pulmonary resection of pulmonary tuberculosis. Korean J Thorac Cardiovasc Surg 1992;25:856-62.
18. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA, et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999;341:1174-9.
19. Kim AJ, Kuh JH, Kim KS. Surgical treatment of pulmonary tuberculosis. Korean J Thorac Cardiovasc Surg 1996;29:397-402.
20. Pomerantz M. Madsen L, Goble M, Iseman MD. Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. Ann Thorac Surg 1991;52:1108-11.
21. Kaplan G, Post FA, Moreira AL, Wainwright H, Kreiswirth BN, Tanverdi M, et al. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect Immun 2003;71:7099-108.
22. Post FA, Willcox PA, Mathema B, Steyn LM, Shean K, Ramaswamy SV, et al. Genetic polymorphisms in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis. J Infect Dis 2004;190:99-106.
23. Song W, Woo HJ, Kim JS, Lee KM. In vitro activity of beta-lactams in combination with other antimicrobial agents against resistant strains of Pseudomonas aeruginosa. Int J Antimicrob Agents 2003;21:8 -12.
24. Yoon J, Urban C, Terzian C, Mariano N, Rahal JJ. In vitro double and triple synergistic activities of polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2004;48:753-7.
25. Fish DN, Choi MK, Jung R. Synergic activity of cephalosporins plus fluoroquinolones against Pseudomonas aeruginosa with resistance to one or both drugs. J Antimicrob Chemother 2002;50:1045-9.
26. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug resistant Acinetobacter baumannii. Clin Infect Dis 2003;36:1268-74.